582 related articles for article (PubMed ID: 24332218)
21. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis.
Horak F; Unkauf M; Beckers C; Mittermaier EM
Arzneimittelforschung; 2000 Dec; 50(12):1099-105. PubMed ID: 11190775
[TBL] [Abstract][Full Text] [Related]
22. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.
Kaiser HB; Naclerio RM; Given J; Toler TN; Ellsworth A; Philpot EE
J Allergy Clin Immunol; 2007 Jun; 119(6):1430-7. PubMed ID: 17418384
[TBL] [Abstract][Full Text] [Related]
23. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis.
Frieri M; Therattil J; Chavarria V; Cosachov J; Kumar NS; Wang SF; Sansone G; Etzel J; Dellevecchia D; Zitt M; Mesarina-Wicki B; Nolop KB
Ann Allergy Asthma Immunol; 1998 Nov; 81(5):431-7. PubMed ID: 9860036
[TBL] [Abstract][Full Text] [Related]
24. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
25. The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis.
Bareille P; Murdoch RD; Denyer J; Bentley J; Smart K; Yarnall K; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):576-84. PubMed ID: 23735181
[TBL] [Abstract][Full Text] [Related]
26. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
27. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
28. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
[TBL] [Abstract][Full Text] [Related]
30. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
[TBL] [Abstract][Full Text] [Related]
31. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
[TBL] [Abstract][Full Text] [Related]
32. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
Howland WC; Amar NJ; Wheeler W; Sacks H
Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis.
Ratner P; Van Bavel J; Mohar D; Jacobs RL; Hampel F; Howland W; Karwal R
Ann Allergy Asthma Immunol; 2015 Feb; 114(2):141-7. PubMed ID: 25624132
[TBL] [Abstract][Full Text] [Related]
35. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
36. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn).
Dykewicz MS; Kaiser HB; Nathan RA; Goode-Sellers S; Cook CK; Witham LA; Philpot EE; Rickard K
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):44-8. PubMed ID: 12877448
[TBL] [Abstract][Full Text] [Related]
37. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
38. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
[TBL] [Abstract][Full Text] [Related]
40. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
